MAHIDOL UNIVERSITY

Patent Applications and Registrations

Patent applications and USPTO patent grants for MAHIDOL UNIVERSITY.The latest application filed is for "antibody against chikungunya virus or antigen-binding fragment of the antibody, and use of the same".

Company Profile

2.10.10

MAHIDOL UNIVERSITY - Phuttamonthon, Nakhon Pathom TH
Mahidol University - Nakhon Pathom TH
MAHIDOL UNIVERSITY - Bangkok TH
MAHIDOL UNIVERSITY - Salaya Nakhon TH
MAHIDOL UNIVERSITY - Singapore SG
Mahidol University - N/A
Mahidol University - Nakhonpathom QC
MAHIDOL UNIVERSITY - Salaya, Nakhon Pathom TH
Mahidol University -
Mahidol University - Nakompathom TH
Mahidol University - Nakornpathom TH
Mahidol University - 999 Phuttamontol 4 Road Amphur Phutthamontol Nakornpathom TH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibody Against Chikungunya Virus Or Antigen-binding Fragment Of The Antibody, And Use Of The Same App 20200399349 - SHIODA; Tatsuo ; et al.	2020-12-24
Avirulent, immunogenic flavivirus chimeras Grant 10,335,478 - Kinney , et al.	2019-07-02
Selective Alpha-7 Nicotinic Receptor Agonists And Methods For Making And Using Them App 20180244653 - TAYLOR; Palmer ; et al.	2018-08-30
Risk assessment for cutaneous adverse drug reactions from antiretroviral agent Grant 9,557,341 - Sungkanuparph , et al. January 31, 2	2017-01-31
Avirulent, Immunogenic Flavivirus Chimeras App 20160367658 - Kinney; Richard M. ; et al.	2016-12-22
Avirulent, immunogenic flavivirus chimeras Grant 9,463,233 - Kinney , et al. October 11, 2	2016-10-11
Method For Detecting Disease Biomarkers App 20150111238 - Tang; Kai ; et al.	2015-04-23
Avirulent, Immunogenic Flavivirus Chimeras App 20140141040 - Kinney; Richard M. ; et al.	2014-05-22
Avirulent, immunogenic flavivirus chimeras Grant 8,673,316 - Kinney , et al. March 18, 2	2014-03-18
Biomarkers For Dengue App 20120021936 - Ward; Brian ; et al.	2012-01-26
Risk Assessment For Cutaneous Adverse Drug Reactions From Antiretroviral Agent App 20110301043 - Sungkanuparph; Somnuek ; et al.	2011-12-08
Avirulent, immunogenic flavivirus chimeras Grant 8,025,887 - Kinney , et al. September 27, 2	2011-09-27
Determination of risk of developing dengue hemorrhagic fever/dengue shock syndrome, methods and compositions therefor Grant 7,629,117 - Avirutnan , et al. December 8, 2	2009-12-08
Determination Of Risk Of Developing Dengue Hemorrhagic Fever/dengue Shock Syndrome, Methods And Compositions Therefor App 20080113338 - Avirutnan; Panisadee ; et al.	2008-05-15
Andrographis paniculata gel as an adjunct in the treatment of periodontitis Grant 7,135,164 - Rojanapanthu , et al. November 14, 2	2006-11-14
Ribonuclease zymogen design Grant 7,098,016 - Raines , et al. August 29, 2	2006-08-29
Andrographis paniculata gel as an adjunct in the treatment of periodontitis App 20030091517 - Rojanapanthu, Pleumchitt ; et al.	2003-05-15

Company Registrations

NCAGE Code	SGJ17	MAHIDOL UNIVERSITY
NCAGE Code	SCH70	MAHIDOL UNIVERSITY
CAGE Code	SCH70	MAHIDOL UNIVERSITY
CAGE Code	SGJ17	MAHIDOL UNIVERSITY
S.A.M. Registration	SGJ17 [660984043]	MAHIDOL UNIVERSITY

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.